https://www.selleckchem.com/pr....oducts/2-3-butanedio
Intranasal administration of EPO combined with other antioxidant and anti-inflammatory compounds could become an effective therapeutic alternative, to avoid and/or slow down neurodegenerative deterioration without producing adverse peripheral effects. On-road driving behavior can be impaired in older drivers and particularly in drivers with mild cognitive impairment (MCI). To determine whether cognitive and non-cognitive risk factors for driving safety may allow an accurate and economic prediction of on-road driving s
Like
Comment
Share
